Dual regulation of somatostatin receptor subtype 1 gene expression by Pit-1 in anterior pituitary GH3 cells

Molecular Endocrinology

Volumn 14, Issue 2, 2000, Pages 255-271

  Baumeister, Hans ^a   Wegner, Michael ^b   Richter, Dietmar ^b   Meyerhof, Wolfgang ^a,c  

^a UNIVERSITY OF POTSDAM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; GROWTH HORMONE; MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GROWTH HORMONE RELEASE; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0034456068     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.2.0419     Document Type: Article

References (86)

1. Somatostatin: The neuroendocrine story
2. 3) proliferation in vitro
3. 3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block
4. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy
5. Molecular mechanisms of the antiproliferative effect of somatostatin: Involvement of a tyrosine phosphatase
6. The elucidation of somatostatin receptor functions: A current view
7. Molecular pharmacology of somatostatin receptors
8. Pharmacological properties of two cloned somatostatin receptors
9. Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides
10. Coexpression of somatostatin SSTR-4 and SSTR-3 receptor mRNAs in the rat central nervous system
11. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
12. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary
13. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas
14. Acromegaly
15. Somatostatin receptor subtype gene expression in pituitary adenomas
16. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
17. Development of a selective agonist at the somatostatin receptor subtype sstr1
18. 2+-currents in rat insulinoma 1046-38 cells
19. Expression patterns of rat Somatostatin receptor genes in pre- and postnatal brain and pituitary
20. Pit-1 determines cell types during development of the anterior pituitary gland
21. Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene
22. Transcriptional control of pituitary gene expression
23. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein
24. Regulatory elements controlling pituitary-specific expression of the human prolactin gene
25. Pituitary ontogeny of the Snell dwarf mouse reveals Pit-1-independent and Pit-1-dependent origins of the thyrotrope
26. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1
27. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells
28. 1 cells
29. Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effect on growth hormone and prolactin release in rat pituitary cell cultures
30. Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter
31. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions
32. A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression
33. POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter
34. A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells
35. Differential splicing of the GHF1 primary transcript gives rise to two functionally distinct homeodomain proteins
36. Pituitary cell Line GH3 expresses two somatostatin receptor subtypes that inhibit adenylyl cyclase: Functional expression of rat somatostatin receptor subtypes 1 and 2 in human embryonic kidney 293 cells
37. Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site
38. Transcriptional activation by Sp1 as directed through TATA or initiator: Specific requirement for mammalian transcription factor IID
39. Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene
40. Characterization of the 5′-flanking promoter region of the rat somatostatin receptor subtype 3 gene
41. Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness
42. Sequence analysis of the 5′-flanking promoter region of the human somatostatin receptor 5
43. The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene
44. CCAAT/enhancer-binding protein alpha activation of the rat growth hormone promoter in pituitary progenitor GHFT1-5 cells
45. Calcium-regulated phosphorylation within the leucine zipper of C/EBP β
46. Pituitary and hypothalamic somatostatin receptor subtype mRNA expression in the food deprived and diabetic rat
47. Inhibition of mineralocorticoid activity by the β-isoform of the human glucocorticoid receptor
48. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity
49. The molecular basis of thyroid hormone action
50. Regulation of gene expression by insulin
51. Negative regulation of gene expression by TGF-β
52. Conserved mechanism of negative gene regulation by extracellular calcium. Parathyroid hormone gene versus atrial natriuretic polypeptide gene
53. Negative regulation of transcription in eukaryotes
54. An alternatively spliced form of Pit-1 represses prolactin gene expression
55. Specific repression of rat prolactin gene expression in transplanted tumor cells
56. A Thyrotrope-specific variant of Pit-1 transactivates the thyrotropin β promoter
57. An alternatively spliced Pit-1 isoform altered in its ability to trans-activate
58. Signal-specific co-activator domain requirements for Pit-1 activation
59. Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements
60. The hypothalamic-pituitary axis: Co-development of two organs
61. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth
62. Somatostatin acts by inhibiting the cyclic 3′, 5′-adenosine monophosphate (cAMP)/protein kinase A pathway, cAMP response element -binding protein (CREB) phosphorylation, and CREB transcription potency
63. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth-hormone-releasing factor gene
64. Nuclear effects of the cAMP pathway activation in somatotrophs
65. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain
66. Distribution of somatostatin receptors 1, 2 and 3 mRNA in rat brain and pituitary
67. Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2 and SSTR3 in adult rat brain: Analysis by RNA blotting and in situ hybridization histochemistry
68. Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: Relationship to neuroendocrine function
69. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue
70. Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract
71. Expression of a large family of POU-domain regulatory genes in mammalian brain development
72. POU-domain gene expression in the gastrointestinal tract
73. Cloning and expression of a rat somatostatin receptor enriched in brain
74. Function of the homeodomain protein GHF1 in pituitary cell proliferation
75. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity
76. Exonuclease III: Use for DNA sequence analysis and in specific deletions of nucleotides
77. Recombinant PCR
78. An optimised electroporation protocol applicable to a wide range of cell lines
79. Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA
80. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
81. Identification of proteins interacting with the enhancer of human U2 small nuclear RNA genes
82. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
83. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses
84. Cloning of a cDNA encoding a novel putative G-protein-coupled receptor expressed in specific rat brain regions
85. Growth hormone gene expression in eukariotic cells directed by the Rous sarcoma virus long terminal repeat or cytomegalovirus immediate-early promoter
86. Somatotrop- and lactotroph-specific interactions with the homeobox protein binding sites in the rat growth hormone gene promoter